Livestock productions must implement conditions that promote good health status, without sacrificing profitability. There are alternatives that allow it by impacting zootechnical parameters, without raising production costs. One of the most common alternatives is the use of antibiotics as animal growth promoters.
In Colombia there are regulations about the use of these in livestock production, so here is a summary of what they are and what they consist of:
|Documents approved by the National Council for Economic and Social Policy (CONPES)|
Establishes the sanitary and food safety policy in Colombia to:
CONPES 3376: Beef and milk
CONPES 3458: Pork meat
CONPES 3468: Poultry products
CONPES 155: National pharmaceutical policy
|Resolution No. 1326 of June 30th, 1981 of the Colombian Agricultural Institute (ICA)||Provisions are made for the use and marketing of antimicrobial products for veterinary use.|
Resolución No. 1966 del 5 de septiembre de 1984 del Instituto Colombiano Agropecuario (ICA)
|Regulates the use of antibiotics as growth promoting substances or feed efficiency enhancers.|
|Resolution 1082 of 1995||Where by the use and marketing of Furazolidone, Nitrofurazone and Furaltadone for animal use is prohibited.|
Resolution 00961 of 2003
For which the oral administration of Gentian Violet in animals is prohibited.
Resolution 991 of 2004
Whereby the use and marketing of Dimetridazole for animal use is prohibited.
|Decree 3518 of October 9th, 2006 of|
the Ministry of Health and Social Protection
|The Public Health Surveillance System (SIVIGILA) of the INS (National Institute of Health) is created and regulated.|
|Resolutions 2341 and 2640 of August 23rd and September 28th, 2007 of ICA respectively|
Whereby the sanitary and safety conditions in the primary production of cattle and buffalo/swine destined for slaughter for human consumption are regulated.
|Resolution 3585 of October 23rd||Safety assurance in primary production. Restriction of the use of antibiotics as growth promoters, when such substances are used as therapeutic agents in human medicine or veterinary medicine.|
|Resolution 969 of 2010||The use and commercialization of Olaquindox in animal production is prohibited.|
Resolution 2638 of 2010
By means of which Diethylstilbestrol is prohibited.
|Resolution No. 1382 of May 2nd 2013|
of the Ministry of Health and Social Protection
|Establishes maximum limits for residues of antibiotics and other veterinary drugs in food of animal origin intended for human consumption.|
|AUNAP, National Plan for the Development of Sustainable Aquaculture in Colombia. February|
|Weaknesses are evident in issues related to the safety of aquaculture products. Particular reference to the indiscriminate use of antibiotics, especially in the production of ornamental fish.|
|Resolution 7168 of 2016||Whereby the ingredient arsenic and arsenical compounds are prohibited in the guaranteed composition of animal feed and veterinary drugs.|
|Resolution 22747 April 9th, ICA 2018||By means of which the import, manufacture, registration, commercialization and use of additives containing Polymyxin E (colistin) and Polymyxin B as growth promoters in animal species that produce food for human consumption are prohibited.|
It is an ethical aspect to raise animals under appropriate conditions of management, health and nutrition, which do not need permanent medication.
At Bialtec we offer high-precision additives, which act as functional ingredients that must be included in compound animal feed to improve performance and results in each species and at each stage of life, through a patented microencapsulation technology that addresses the needs of the productive processes of the compound animal feed manufacturing market, regarding the conditions of pressure, pH, temperature, among others, to guarantee an effective action once they are released in a controlled way in the intestine of the animal.
If you are interested in compliying with national regulations without jeopardizing the biosecurity conditions of your production and without sacrificing profitability, contact us!
Por: Catalina Bedoya – Technical Commercial Analyst